Abirateron Spirig HC 250 mg, Filmtabletten - 56 Swissmedic Key 68141001 Registration Holder Spirig HealthCare AG Name Abirateron Spirig HC 250 mg, Filmtabletten Date of registration 20.10.2021 Introduction of Sequence 20.10.2021 ATC-Classification Abiraterone (L02BX03) Revision date WHO WHO-DDD Valid until 19.10.2026 Index Therapeuticus (BSV) 07.16.20. Show package size 56 Index Therapeuticus (Swissmedic) 07.16.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680681410010 Medication Code Synthetika Pharmacode Disponibility
Composition abirateroni acetas 250.00 mg corresp. abirateronum 223 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 30, cellulosum microcristallinum, lactosum monohydricum 34.00 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 5.3 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Abirateroni Acetas 250 mg correspond Abirateronum 223 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Lactose Monohydrate 34 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Povidonum K 30 Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
